Smoking resumption after heart or lung transplantation: a systematic review and suggestions for screening and management

被引：24

作者：

Hofmann, Patrick ^{[1
]}

Benden, Christian ^{[1
]}

Kohler, Malcolm ^{[1
,2
]}

Schuurmans, Mace M. ^{[1
,2
]}

机构：

[1] Univ Hosp Zurich, Div Pulmonol, Zurich, Switzerland

[2] Univ Zurich, Zurich, Switzerland

来源：

JOURNAL OF THORACIC DISEASE | 2018年 / 10卷 / 07期

关键词：

Smoking resumption; heart and lung transplantation; smoking cessation; nicotine replacement; bupropion; varenicline; INTERNATIONAL-SOCIETY; BRONCHOGENIC-CARCINOMA; CARBON-MONOXIDE; LIVER-INJURY; NICOTINE; TOBACCO; CANDIDATES; CESSATION; VARENICLINE; BUPROPION;

D O I：

10.21037/jtd.2018.07.16

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Smoking remains the leading cause of preventable disease and death in the developed world and kills half of all long-term users. Smoking resumption after heart or lung transplantation is associated with allograft dysfunction, higher incidence of cancer, and reduced overall survival. Although self-reporting is considered an unreliable method for tobacco use detection, implementing systematic cotinine-based screening has proven challenging. This review examines the prevalence of smoking resumption in thoracic transplant patients, explores the risk factors associated with a post-transplant smoking resumption and discusses the currently available smoking cessation interventions for transplant patients.

引用

页码：4609 / 4618

页数：10

共 65 条

[21]

Evangelista LS, 2009, J CARD FAIL, V15, pS103, DOI 10.1111/j.1751-7117.2009.00049.x

[22] Tobacco and alcohol use in lung transplant candidates and recipients [J].

Evon, DM ;

Burker, EJ ;

Sedway, JA ;

Cicale, R ;

Davis, K ;

Egan, T .

CLINICAL TRANSPLANTATION, 2005, 19 (02) :207-214

[23] A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Varenicline for Smoking Cessation [J].

Faessel, Helene M. ;

Obach, R. Scott ;

Rollema, Hans ;

Ravva, Patanjali ;

Williams, Kathryn E. ;

Burstein, Aaron H. .

CLINICAL PHARMACOKINETICS, 2010, 49 (12) :799-816

[24] The epidemiology of smoking -: Health consequences and benefits of cessation [J].

Fagerström, K .

DRUGS, 2002, 62 (Suppl 2) :1-9

[25] Cardiovascular and mortality risks in older Medicare patients treated with varenicline or bupropion for smoking cessation: an observational cohort study [J].

Graham, David J. ;

By, Kunthel ;

McKean, Stephen ;

Mosholder, Andrew ;

Kornegay, Cynthia ;

Racoosin, Judith A. ;

Young, Jessica ;

Levenson, Mark ;

MaCurdy, Thomas E. ;

Worrall, Chris ;

Kelman, Jeffrey A. .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (11) :1205-1212

[26]

Hitchings Andrew W., 2016, Adverse Drug Reaction Bulletin, V298

[27] Risk Factors of Lung, Head and Neck, Esophageal, and Kidney and Urinary Tract Carcinomas After Liver Transplantation: The Effect of Smoking Withdrawal [J].

Ignacio Herrero, J. ;

Pardo, Fernando ;

D'Avola, Delia ;

Alegre, Felix ;

Rotellar, Fernando ;

Inarrairaegui, Mercedes ;

Marti, Pablo ;

Sangro, Bruno ;

Quiroga, Jorge .

LIVER TRANSPLANTATION, 2011, 17 (04) :402-408

[28] CARBON-MONOXIDE AND THIOCYANATE LEVELS IN LOW TAR-NICOTINE SMOKERS [J].

JAFFE, JH ;

KANZLER, M ;

FRIEDMAN, L ;

STUNKARD, AJ ;

VEREBEY, K .

ADDICTIVE BEHAVIORS, 1981, 6 (04) :337-343

[29] Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation -: A randomized controlled trial [J].

Jorenby, Douglas E. ;

Hays, J. Taylor ;

Rigotti, Nancy A. ;

Azoulay, Salomon ;

Watsky, Eric J. ;

Williams, Kathryn E. ;

Billing, Clare B. ;

Gong, Jason ;

Reeves, Karen R. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (01) :56-63

[30] E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis [J].

Kalkhoran, Sara ;

Glantz, Stanton A. .

LANCET RESPIRATORY MEDICINE, 2016, 4 (02) :116-128

← 1 2 3 4 5 6 7 →